Search
- Jan 18, 2023
CMC and margins make cell and gene therapy a different kind of medicine
Dark Horse Consulting's Anthony Davies discusses CMC issues to consider when developing cell and gene therapies.
- Jan 18, 2023
Talking cell therapy with the co-inventor of CAR-T
UPenn's Bruce Levine catches us up on the latest in cell therapy at #ATW23.
- Jan 18, 2023
Atara's Pascal Touchon on allo
Atara Biotherapeutics' CEO Pascal Touchon discusses his company's approved allogeneic cell therapy, and the EBV theory of MS.
- Jan 18, 2023
UCSF's Nicole Paulk discusses AAV as a gene therapy vector
UCSF's Nicole Paulk discusses AAV as a gene therapy vector at Advanced Therapies Week in Miami Beach.
- Jan 18, 2023
How CAR-T and gene therapies are shipped
Cryoport's Mark Sawicki demonstrates how CAR-T and gene therapies are shipped in high tech shipping containers.
- Jan 11, 2023
The latest on immunotherapy with John Connolly.
Parker Institute's John Connolly provides an update on the latest in cancer immunotherapy at #JPM23.